Sun Jian-Song, Yang Xiu-Hai
Department of Otolaryngology-Head and Neck Surgery, The People's Hospital of Guizhou Province, Guiyang, Guizhou 550002, P.R. China.
Exp Ther Med. 2018 Apr;15(4):3295-3301. doi: 10.3892/etm.2018.5826. Epub 2018 Feb 1.
The aim of the present study was to explore the expression and distribution of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) in tumor tissues and adjacent normal mucosa tissues of patients with laryngeal squamous cell carcinoma (LSCC), and further analyze the association between the expression and the clinicopathological parameters of patients with LSCC. Clinical data of tumor tissues and corresponding adjacent normal mucosa tissues of pathologically diagnosed LSCC in 96 cases were collected in the present study. Of these specimens, the mRNA and protein expression levels of DNA-PKcs in LSCC tissues and the adjacent normal mucosa tissues were analyzed via reverse transcription-quantitative polymerase chain reaction and western blot analysis. Immunohistochemistry was used to detect expression and distribution of DNA-PKcs protein in LSCC tissues and corresponding adjacent normal mucosa tissues. The association between DNA-PKcs expression and the specific clinicopathologic features was evaluated by the χ test. Kaplan-Meier and Cox proportional hazards regression models were used to analyze the data. It was revealed that the expression of DNA-PKcs mRNA and protein was significantly higher in LSCC tissues than the adjacent normal mucosa tissues (P<0.05). DNA-PKcs was expressed predominantly in the nucleus. DNA-PKcs expression showed significant correlation with the differentiation degree of LSCC (P<0.05), and changes of DNA-PKcs expression gradually increased with the decrease of the differentiation degree. However, DNA-PKcs expression was not significantly associated with sex, age, lymph node metastasis or TMN stage (P>0.05). Patients with LSCC exhibited higher DNA-PKcs expression had markedly shorter survival than those with lower DNA-PKcs expression. In conclusion, the present results suggested that the expression levels of DNA-PKcs were significantly increased in LSCC tumor tissues than in adjacent normal mucosa. DNA-PKcs expression was correlated with differentiation of LSCC, and may become a novel prognostic marker for patients with LSCC.
本研究旨在探讨DNA依赖性蛋白激酶催化亚基(DNA-PKcs)在喉鳞状细胞癌(LSCC)患者肿瘤组织及癌旁正常黏膜组织中的表达及分布情况,并进一步分析其表达与LSCC患者临床病理参数之间的关系。本研究收集了96例经病理诊断为LSCC患者的肿瘤组织及相应癌旁正常黏膜组织的临床资料。采用逆转录-定量聚合酶链反应和蛋白质印迹法分析这些标本中LSCC组织及癌旁正常黏膜组织中DNA-PKcs的mRNA和蛋白表达水平。采用免疫组织化学法检测DNA-PKcs蛋白在LSCC组织及相应癌旁正常黏膜组织中的表达及分布。采用χ²检验评估DNA-PKcs表达与特定临床病理特征之间的关系。使用Kaplan-Meier法和Cox比例风险回归模型分析数据。结果显示,LSCC组织中DNA-PKcs的mRNA和蛋白表达明显高于癌旁正常黏膜组织(P<0.05)。DNA-PKcs主要在细胞核中表达。DNA-PKcs表达与LSCC的分化程度显著相关(P<0.05),且随着分化程度降低,DNA-PKcs表达变化逐渐增加。然而,DNA-PKcs表达与性别、年龄、淋巴结转移或TMN分期无显著相关性(P>0.05)。LSCC患者中DNA-PKcs表达较高者的生存期明显短于DNA-PKcs表达较低者。综上所述,本研究结果提示,LSCC肿瘤组织中DNA-PKcs的表达水平明显高于癌旁正常黏膜组织。DNA-PKcs表达与LSCC的分化相关,可能成为LSCC患者的一种新型预后标志物。